MonTa Biosciences ApS: Financial statements 2024
CVR: 36697016
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MonTa Biosciences ApS (CVR 36697016) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,479,565 and a net result of DKK -3,920,572 compared with DKK -3,278,626 the year before. That is a decrease of 26.9% compared with the year before. Equity in the 2024 report amounted to DKK -5,527,696. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,479,565
- Profit/Loss
- DKK -3,920,572
- Equity
- DKK -5,527,696
- Total Assets
- DKK 83,383,702
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.5 mio. | -3.9 mio. | -5.5 mio. | 3 |
| 2023 | - | 2 mio. | -3.3 mio. | -1.6 mio. | 4 |
| 2022 | - | 1.8 mio. | -1.4 mio. | 1.7 mio. | 3 |
| 2021 | - | 2.1 mio. | 1.4 mio. | 3.1 mio. | 3 |
| 2020 | - | -13.3 mio. | -13.3 mio. | 1.7 mio. | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MonTa Biosciences ApS has published its annual report for 2023. Gross profit came to DKK 2,024,634, and the net result was DKK -3,278,626.
About MonTa Biosciences ApS
MonTa Biosciences ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MonTa Biosciences IVS. The management consists of Simon Skjøde Jensen. The board consists of Lone Schøtt Kunøe (chair), Esper Boel, Sven Madsen and Søren Tulstrup. The company's owners include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. Equity in the 2025 report amounted to DKK -10,304,549.